and/or
10 News Items found
In the Lab
Two abstract paintings, one in color and one in black and white.
Science Meets Art to Build a Paintable Diagnostic Test for Cancer
A collaboration between a nanotechnology scientist and a visual artist leads to a promising diagnostic test and a new art form.
Feature
Side-by-side images of brain MRIs.
New Imaging Technique Provides Snapshot of Brain Tumor Activity
A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.
In the Clinic
Hyperpolarized MRI
Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days
Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Finding
Pictured: Gabriela Chiosis
Hsp90: A Very Promising Target for Cancer Therapy
A small molecule discovered at MSK called PU-H71 blocks the growth of cancer cells and enables doctors to image tumors.
In the Clinic
Pictured: Serge Lyashchenko
How Our New Particle Accelerator Will Make Cancer Imaging and Treatment More Precise
The launch of a 20-ton instrument and a facility for producing radioactive imaging molecules will allow our doctors and scientists to monitor cancers in unparalleled detail.
In the Lab
Pictured: Jan Grimm
Spongelike Particles Show Promise for Delivering Drugs to Tumors
Memorial Sloan Kettering researchers are investigating the use of tiny particles that behave like sponges to take in drugs and deliver them to tumors.
In the Lab
Pictured: Daniel Thorek & Jan Grimm
Faster than the Speed of Light: New Imaging Approach Could Measure Tumor Activity
A new imaging approach being investigated by Memorial Sloan Kettering researchers could provide better information about a tumor’s molecular activity, allowing for a more accurate diagnosis.
In the Lab
Pictured: PET Scan
New Imaging Agent Could Improve Prostate Cancer Diagnosis and Treatment
Researchers at Memorial Sloan Kettering are developing a new strategy for PET imaging of tumors that could result in new tools to detect and monitor prostate cancer.
In the Clinic
Pictured: Michael Morris
Bone Scan Index May Help Determine Response to Prostate Cancer Treatment
Researchers at Memorial Sloan Kettering have shown the usefulness of a scale called the Bone Scan Index (BSI) for determining whether some prostate cancer patients are responding to therapy.
Feature
An illustration
Out of the Lab and into the World: Scientific and Medical Inventions Benefit Cancer Patients
Memorial Sloan Kettering scientists, physicians, and administrators are developing and commercializing research discoveries to generate more-effective and affordable cancer treatments.